A citation-based method for searching scientific literature

U M Schrell, M G Rittig, M Anders, U H Koch, R Marschalek, F Kiesewetter, R Fahlbusch. J Neurosurg 1997
Times Cited: 132







List of co-cited articles
712 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Stabilization of disease progression by hydroxyurea in patients with recurrent or unresectable meningioma.
Warren P Mason, Fred Gentili, David R Macdonald, Subramanian Hariharan, Charlene R Cruz, Lauren E Abrey. J Neurosurg 2002
104
52


Non-resectable slow-growing meningiomas treated by hydroxyurea.
David Loven, Ruth Hardoff, Zvi Bar Sever, Adam P Steinmetz, Michael Gornish, Zvi H Rappaport, Eyal Fenig, Zvi Ram, Aaron Sulkes. J Neurooncol 2004
59
66

Hydroxyurea chemotherapy for unresectable or residual meningioma.
H B Newton, M A Slivka, C Stevens. J Neurooncol 2000
75
50

Temozolomide for treatment-resistant recurrent meningioma.
Marc C Chamberlain, Denice D Tsao-Wei, Susan Groshen. Neurology 2004
101
37

The treatment of recurrent unresectable and malignant meningiomas with interferon alpha-2B.
S E Kaba, F DeMonte, J M Bruner, A P Kyritsis, K A Jaeckle, V Levin, W K Yung. Neurosurgery 1997
95
36

Treatment of high risk or recurrent meningiomas with hydroxyurea.
Mark A Rosenthal, David L Ashley, Lawrence Cher. J Clin Neurosci 2002
49
69

A phase II evaluation of tamoxifen in unresectable or refractory meningiomas: a Southwest Oncology Group study.
J W Goodwin, J Crowley, H J Eyre, B Stafford, K A Jaeckle, J J Townsend. J Neurooncol 1993
98
33

Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08).
Patrick Y Wen, W K Alfred Yung, Kathleen R Lamborn, Andrew D Norden, Timothy F Cloughesy, Lauren E Abrey, Howard A Fine, Susan M Chang, H Ian Robins, Karen Fink,[...]. Neuro Oncol 2009
90
36

Salvage chemotherapy with CPT-11 for recurrent meningioma.
Marc C Chamberlain, Denice D Tsao-Wei, Susan Groshen. J Neurooncol 2006
64
50

Recurrent meningioma: salvage therapy with long-acting somatostatin analogue.
Marc C Chamberlain, Michael J Glantz, Camilo E Fadul. Neurology 2007
121
32

Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma.
Andrew D Norden, Jeffrey J Raizer, Lauren E Abrey, Kathleen R Lamborn, Andrew B Lassman, Susan M Chang, W K Alfred Yung, Mark R Gilbert, Howard A Fine, Minesh Mehta,[...]. J Neurooncol 2010
108
32



Prolonged oral hydroxyurea and concurrent 3d-conformal radiation in patients with progressive or recurrent meningioma: results of a pilot study.
Barbara M Hahn, Ulrich M H Schrell, Rolf Sauer, Rudolf Fahlbusch, Oliver Ganslandt, Gerhard G Grabenbauer. J Neurooncol 2005
40
75


Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone.
S M Grunberg, M H Weiss, I M Spitz, J Ahmadi, A Sadun, C A Russell, L Lucci, L L Stevenson. J Neurosurg 1991
275
29


Long-term administration of mifepristone (RU486): clinical tolerance during extended treatment of meningioma.
Steven M Grunberg, Martin H Weiss, Christy A Russell, Irving M Spitz, Jamshid Ahmadi, Alfredo Sadun, Regine Sitruk-Ware. Cancer Invest 2006
108
26



Bevacizumab therapy for adults with recurrent/progressive meningioma: a retrospective series.
Emil Lou, Ashley L Sumrall, Scott Turner, Katherine B Peters, Annick Desjardins, James J Vredenburgh, Roger E McLendon, James E Herndon, Frances McSherry, Julie Norfleet,[...]. J Neurooncol 2012
114
23

Atypical and anaplastic meningiomas treated with bevacizumab.
Lakshmi Nayak, Fabio M Iwamoto, Jeremy D Rudnick, Andrew D Norden, Eudocia Quant Lee, Jan Drappatz, Antonio Omuro, Thomas J Kaley. J Neurooncol 2012
110
22

Phase II study of Gleevec® plus hydroxyurea (HU) in adults with progressive or recurrent meningioma.
David A Reardon, Andrew D Norden, Annick Desjardins, James J Vredenburgh, James E Herndon, April Coan, John H Sampson, Sridharan Gururangan, Katherine B Peters, Roger E McLendon,[...]. J Neurooncol 2012
49
42

Mifepristone (RU 486) treatment of meningiomas.
S W Lamberts, H L Tanghe, C J Avezaat, R Braakman, R Wijngaarde, J W Koper, H de Jong. J Neurol Neurosurg Psychiatry 1992
111
20

Chemotherapy for meningiomas.
A P Kyritsis. J Neurooncol 1996
61
31

Meningioma treated with interferon-alpha, evaluated with [(11)C]-L-methionine positron emission tomography.
C Muhr, O Gudjonsson, A Lilja, M Hartman, Z J Zhang, B Långström. Clin Cancer Res 2001
43
41


Phase II study of subcutaneous octreotide in adults with recurrent or progressive meningioma and meningeal hemangiopericytoma.
Derek R Johnson, David W Kimmel, Patrick A Burch, Terrence L Cascino, Caterina Giannini, Wenting Wu, Jan C Buckner. Neuro Oncol 2011
52
32

Medical therapies for meningiomas.
Patrick Y Wen, Eudocia Quant, Jan Drappatz, Rameen Beroukhim, Andrew D Norden. J Neurooncol 2010
102
17

Meningioma: analysis of recurrence and progression following neurosurgical resection.
R O Mirimanoff, D E Dosoretz, R M Linggood, R G Ojemann, R L Martuza. J Neurosurg 1985
760
16



Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma.
Thomas J Kaley, Patrick Wen, David Schiff, Keith Ligon, Sam Haidar, Sasan Karimi, Andrew B Lassman, Craig P Nolan, Lisa M DeAngelis, Igor Gavrilovic,[...]. Neuro Oncol 2015
143
15


Meningioma grading: an analysis of histologic parameters.
A Perry, S L Stafford, B W Scheithauer, V J Suman, C M Lohse. Am J Surg Pathol 1997
454
14

Expression and activation of epidermal growth factor receptors in meningiomas.
R S Carroll, P M Black, J Zhang, M Kirsch, I Percec, N Lau, A Guha. J Neurosurg 1997
65
21


A phase II trial of PTK787/ZK 222584 in recurrent or progressive radiation and surgery refractory meningiomas.
Jeffrey J Raizer, Sean A Grimm, Alfred Rademaker, James P Chandler, Kenji Muro, Irene Helenowski, Laurie Rice, Katie McCarthy, Sandra K Johnston, Maciej M Mrugala,[...]. J Neurooncol 2014
61
22

Radiotherapy for atypical or malignant intracranial meningioma.
M F Milosevic, P J Frost, N J Laperriere, C S Wong, W J Simpson. Int J Radiat Oncol Biol Phys 1996
162
13

Management of atypical and malignant meningiomas: role of high-dose, 3D-conformal radiation therapy.
E B Hug, A Devries, A F Thornton, J E Munzenride, F S Pardo, E T Hedley-Whyte, M R Bussiere, R Ojemann. J Neurooncol 2000
217
13

Autocrine growth stimulation of human meningioma cells by platelet-derived growth factor.
T Todo, E F Adams, R Fahlbusch, T Dingermann, H Werner. J Neurosurg 1996
57
22



Meningioma: current treatment options and future directions.
Kevin P McMullen, Volker W Stieber. Curr Treat Options Oncol 2004
27
48

Bevacizumab-induced regression of anaplastic meningioma.
M J A Puchner, V H Hans, A Harati, F Lohmann, M Glas, U Herrlinger. Ann Oncol 2010
52
25


Expression of somatostatin receptor mRNA in human meningiomas and their implication in in vitro antiproliferative activity.
Sara Arena, Federica Barbieri, Stefano Thellung, Paolo Pirani, Alessandro Corsaro, Valentina Villa, Patrizia Dadati, Alessandra Dorcaratto, Gabriella Lapertosa, Jean-Louis Ravetti,[...]. J Neurooncol 2004
75
16

Aberrant signaling pathways in meningiomas.
Brian T Ragel, Randy L Jensen. J Neurooncol 2010
46
26

Double-Blind Phase III Randomized Trial of the Antiprogestin Agent Mifepristone in the Treatment of Unresectable Meningioma: SWOG S9005.
Yongli Ji, Cathryn Rankin, Steven Grunberg, Andy E Sherrod, Jamshid Ahmadi, Jeannette J Townsend, Lynn G Feun, Ruth K Fredericks, Christy A Russell, Fairooz F Kabbinavar,[...]. J Clin Oncol 2015
65
18


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.